DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,494 filers reported holding DANAHER CORPORATION in Q1 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,207,622 | +0.1% | 40,855 | 0.0% | 0.70% | +2.6% |
Q1 2024 | $10,202,311 | +7.5% | 40,855 | -0.5% | 0.68% | -18.3% |
Q4 2023 | $9,494,425 | -63.1% | 41,041 | -60.5% | 0.83% | -61.7% |
Q3 2023 | $25,748,810 | +3.7% | 103,784 | +0.4% | 2.18% | +5.0% |
Q2 2023 | $24,830,205 | -33.8% | 103,345 | -30.5% | 2.08% | -20.6% |
Q1 2023 | $37,513,898 | -13.1% | 148,685 | -8.5% | 2.62% | -30.8% |
Q4 2022 | $43,189,420 | +2.8% | 162,571 | +0.0% | 3.78% | +3.8% |
Q3 2022 | $42,023,962 | -7.8% | 162,546 | -9.5% | 3.64% | +12.4% |
Q2 2022 | $45,591,592 | -2.8% | 179,659 | +12.4% | 3.24% | -10.0% |
Q1 2022 | $46,903,529 | -16.2% | 159,768 | -6.0% | 3.60% | +0.7% |
Q4 2021 | $55,983,620 | +24.2% | 170,053 | +14.9% | 3.58% | +14.3% |
Q3 2021 | $45,068,183 | -18.0% | 147,938 | -27.7% | 3.13% | -14.6% |
Q2 2021 | $54,975,987 | +37.5% | 204,705 | +15.3% | 3.66% | +21.8% |
Q1 2021 | $39,991,245 | +42.4% | 177,534 | +40.5% | 3.01% | -8.7% |
Q4 2020 | $28,082,373 | +315.5% | 126,330 | +302.8% | 3.29% | +119.3% |
Q3 2020 | $6,757,938 | -64.6% | 31,360 | -70.9% | 1.50% | -42.6% |
Q2 2020 | $19,089,983 | -41.1% | 107,857 | -53.9% | 2.62% | -67.5% |
Q1 2020 | $32,419,197 | +7.1% | 233,957 | +18.7% | 8.06% | +50.7% |
Q4 2019 | $30,281,861 | +17.2% | 197,107 | +10.3% | 5.35% | -33.3% |
Q3 2019 | $25,838,590 | +24.5% | 178,704 | +23.2% | 8.02% | +37.9% |
Q2 2019 | $20,761,378 | -1.1% | 145,104 | -8.6% | 5.81% | -5.0% |
Q1 2019 | $20,985,459 | +325.1% | 158,764 | +232.1% | 6.12% | +129.0% |
Q4 2018 | $4,936,613 | +27.4% | 47,804 | +34.3% | 2.67% | +57.2% |
Q3 2018 | $3,874,427 | – | 35,604 | – | 1.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |